TrialFrontiers in immunology2018

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.

Hilde L Orrem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.